Degui Lin
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Veterinary Oncology Research 18
-
- Veterinary Medicine and Surgery 3
- Co-authors
- Yipeng Jin (28 shared papers)Di Zhang (19 shared papers)Jiahao Lin (19 shared papers)Huihao Xu (7 shared papers)Jiafeng Gao (8 shared papers)Hong Zhang (9 shared papers)Huanan Wang (6 shared papers)Huanan Wang (2 shared papers)
- Journals
- BMC Cancer (3 papers)Frontiers in Veterinary Science (3 papers)Biomedicine & Pharmacotherapy (3 papers)Cell Proliferation (2 papers)PLoS ONE (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Degui Lin
62 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 93
- Drug Discovery 5
- Molecular Medicine 102
- Cancer Research 136
- Biomaterials 119
- Epidemiology 258
Countries citing papers authored by Degui Lin
This map shows the geographic impact of Degui Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Degui Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Degui Lin more than expected).
Fields of papers citing papers by Degui Lin
This network shows the impact of papers produced by Degui Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Degui Lin. The network helps show where Degui Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Degui Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 103 | |
| 2 | 2016 | 92 | |
| 3 | 2017 | 74 | |
| 4 | 2019 | 74 | |
| 5 | 2011 | 72 | |
| 6 | 2009 | 62 | |
| 7 | 2015 | 56 | |
| 8 | 2019 | 53 | |
| 9 | 2005 | 52 | |
| 10 | 2008 | 49 | |
| 11 | 2008 | 47 | |
| 12 | 2021 | 44 | |
| 13 | 2015 | 42 | |
| 14 | 2014 | 41 | |
| 15 | 2013 | 38 | |
| 16 | 2014 | 38 | |
| 17 | 2012 | 37 | |
| 18 | 2017 | 36 | |
| 19 | 2019 | 35 | |
| 20 | 2019 | 31 |
About Degui Lin
Degui Lin is a scholar working on Pulmonary and Respiratory Medicine, Small Animals, Cancer Research, Immunology and Epidemiology, having authored 64 papers that have together received 1.6k indexed citations. Recurring topics across this work include Veterinary Oncology Research (18 papers), Influenza Virus Research Studies (4 papers), Veterinary Medicine and Surgery (3 papers), Nanoparticle-Based Drug Delivery (3 papers), Cancer Cells and Metastasis (2 papers), Immune Response and Inflammation (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Protease and Inhibitor Mechanisms (2 papers). The work is most often cited by research in Drug Discovery (5 citations), Molecular Medicine (102 citations), Cancer Research (136 citations), Biomaterials (119 citations) and Epidemiology (258 citations). Degui Lin has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Yipeng Jin, Di Zhang, Jiahao Lin, Huihao Xu, Jiafeng Gao, Hong Zhang, Huanan Wang, Huanan Wang, Ji Wang and Bin Zhou. Their work appears in journals such as BMC Cancer, Frontiers in Veterinary Science, Biomedicine & Pharmacotherapy, Cell Proliferation and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.